BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 21761156)

  • 21. Sildenafil potentiates bone morphogenetic protein signaling in pulmonary arterial smooth muscle cells and in experimental pulmonary hypertension.
    Yang J; Li X; Al-Lamki RS; Wu C; Weiss A; Berk J; Schermuly RT; Morrell NW
    Arterioscler Thromb Vasc Biol; 2013 Jan; 33(1):34-42. PubMed ID: 23139294
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Involvement of the bone morphogenetic protein system in endothelin- and aldosterone-induced cell proliferation of pulmonary arterial smooth muscle cells isolated from human patients with pulmonary arterial hypertension.
    Yamanaka R; Otsuka F; Nakamura K; Yamashita M; Otani H; Takeda M; Matsumoto Y; Kusano KF; Ito H; Makino H
    Hypertens Res; 2010 May; 33(5):435-45. PubMed ID: 20186146
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Network of MicroRNAs Mediate Translational Repression of Bone Morphogenetic Protein Receptor-2: Involvement in HIV-Associated Pulmonary Vascular Remodeling.
    Chinnappan M; Mohan A; Agarwal S; Dalvi P; Dhillon NK
    J Am Heart Assoc; 2018 Feb; 7(5):. PubMed ID: 29478969
    [TBL] [Abstract][Full Text] [Related]  

  • 24. LncRNA-TCONS_00034812 in cell proliferation and apoptosis of pulmonary artery smooth muscle cells and its mechanism.
    Liu Y; Sun Z; Zhu J; Xiao B; Dong J; Li X
    J Cell Physiol; 2018 Jun; 233(6):4801-4814. PubMed ID: 29150946
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bone morphogenetic protein signaling in vascular disease: anti-inflammatory action through myocardin-related transcription factor A.
    Wang D; Prakash J; Nguyen P; Davis-Dusenbery BN; Hill NS; Layne MD; Hata A; Lagna G
    J Biol Chem; 2012 Aug; 287(33):28067-77. PubMed ID: 22718766
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dysfunctional Smad signaling contributes to abnormal smooth muscle cell proliferation in familial pulmonary arterial hypertension.
    Yang X; Long L; Southwood M; Rudarakanchana N; Upton PD; Jeffery TK; Atkinson C; Chen H; Trembath RC; Morrell NW
    Circ Res; 2005 May; 96(10):1053-63. PubMed ID: 15845886
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic ablation of the BMPR2 gene in pulmonary endothelium is sufficient to predispose to pulmonary arterial hypertension.
    Hong KH; Lee YJ; Lee E; Park SO; Han C; Beppu H; Li E; Raizada MK; Bloch KD; Oh SP
    Circulation; 2008 Aug; 118(7):722-30. PubMed ID: 18663089
    [TBL] [Abstract][Full Text] [Related]  

  • 28. miRNA-34a promotes proliferation of human pulmonary artery smooth muscle cells by targeting PDGFRA.
    Wang P; Xu J; Hou Z; Wang F; Song Y; Wang J; Zhu H; Jin H
    Cell Prolif; 2016 Aug; 49(4):484-93. PubMed ID: 27302634
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Smad-dependent and smad-independent induction of id1 by prostacyclin analogues inhibits proliferation of pulmonary artery smooth muscle cells in vitro and in vivo.
    Yang J; Li X; Al-Lamki RS; Southwood M; Zhao J; Lever AM; Grimminger F; Schermuly RT; Morrell NW
    Circ Res; 2010 Jul; 107(2):252-62. PubMed ID: 20522807
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Sex-Specific MicroRNA-96/5-Hydroxytryptamine 1B Axis Influences Development of Pulmonary Hypertension.
    Wallace E; Morrell NW; Yang XD; Long L; Stevens H; Nilsen M; Loughlin L; Mair KM; Baker AH; MacLean MR
    Am J Respir Crit Care Med; 2015 Jun; 191(12):1432-42. PubMed ID: 25871906
    [TBL] [Abstract][Full Text] [Related]  

  • 31. NF-κB mediated miR-130a modulation in lung microvascular cell remodeling: Implication in pulmonary hypertension.
    Li L; Kim IK; Chiasson V; Chatterjee P; Gupta S
    Exp Cell Res; 2017 Oct; 359(1):235-242. PubMed ID: 28755990
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PDGFBB promotes proliferation and migration via regulating miR-1181/STAT3 axis in human pulmonary arterial smooth muscle cells.
    Qian Z; Li Y; Yang H; Chen J; Li X; Gou D
    Am J Physiol Lung Cell Mol Physiol; 2018 Dec; 315(6):L965-L976. PubMed ID: 30211651
    [TBL] [Abstract][Full Text] [Related]  

  • 33. miR-223 reverses experimental pulmonary arterial hypertension.
    Meloche J; Le Guen M; Potus F; Vinck J; Ranchoux B; Johnson I; Antigny F; Tremblay E; Breuils-Bonnet S; Perros F; Provencher S; Bonnet S
    Am J Physiol Cell Physiol; 2015 Sep; 309(6):C363-72. PubMed ID: 26084306
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MicroRNA-138 and MicroRNA-25 Down-regulate Mitochondrial Calcium Uniporter, Causing the Pulmonary Arterial Hypertension Cancer Phenotype.
    Hong Z; Chen KH; DasGupta A; Potus F; Dunham-Snary K; Bonnet S; Tian L; Fu J; Breuils-Bonnet S; Provencher S; Wu D; Mewburn J; Ormiston ML; Archer SL
    Am J Respir Crit Care Med; 2017 Feb; 195(4):515-529. PubMed ID: 27648837
    [TBL] [Abstract][Full Text] [Related]  

  • 35. LincRNA-Cox2 promotes pulmonary arterial hypertension by regulating the let-7a-mediated STAT3 signaling pathway.
    Cheng G; He L; Zhang Y
    Mol Cell Biochem; 2020 Dec; 475(1-2):239-247. PubMed ID: 32803651
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MiR-125a-5p ameliorates monocrotaline-induced pulmonary arterial hypertension by targeting the TGF-β1 and IL-6/STAT3 signaling pathways.
    Cai Z; Li J; Zhuang Q; Zhang X; Yuan A; Shen L; Kang K; Qu B; Tang Y; Pu J; Gou D; Shen J
    Exp Mol Med; 2018 Apr; 50(4):1-11. PubMed ID: 29700287
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Autophagy contributes to BMP type 2 receptor degradation and development of pulmonary arterial hypertension.
    Gomez-Puerto MC; van Zuijen I; Huang CJ; Szulcek R; Pan X; van Dinther MA; Kurakula K; Wiesmeijer CC; Goumans MJ; Bogaard HJ; Morrell NW; Rana AA; Ten Dijke P
    J Pathol; 2019 Nov; 249(3):356-367. PubMed ID: 31257577
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Correction of nonsense BMPR2 and SMAD9 mutations by ataluren in pulmonary arterial hypertension.
    Drake KM; Dunmore BJ; McNelly LN; Morrell NW; Aldred MA
    Am J Respir Cell Mol Biol; 2013 Sep; 49(3):403-9. PubMed ID: 23590310
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MEF2C-MYOCD and Leiomodin1 Suppression by miRNA-214 Promotes Smooth Muscle Cell Phenotype Switching in Pulmonary Arterial Hypertension.
    Sahoo S; Meijles DN; Al Ghouleh I; Tandon M; Cifuentes-Pagano E; Sembrat J; Rojas M; Goncharova E; Pagano PJ
    PLoS One; 2016; 11(5):e0153780. PubMed ID: 27144530
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Krüppel-like factor 5 contributes to pulmonary artery smooth muscle proliferation and resistance to apoptosis in human pulmonary arterial hypertension.
    Courboulin A; Tremblay VL; Barrier M; Meloche J; Jacob MH; Chapolard M; Bisserier M; Paulin R; Lambert C; Provencher S; Bonnet S
    Respir Res; 2011 Sep; 12(1):128. PubMed ID: 21951574
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.